Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Uncover the best high cash back cards that charge no annual fees. Maximize your rewards while keeping your costs down.
28,270 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
AMD has delivered a dramatic rally this year, but the big question remains: is the move sustainable? This article bre...
SpaceX’s S-1 filing puts Elon Musk’s Mars ambitions under the public lens, inviting investors to weigh a multi-billio...
Geopolitics can swing oil prices quickly. If Iran talks progress, the market could move fast. This guide shows practi...
Walmart beat Q4 estimates on earnings and revenue but guided FY27 growth below consensus, sparking bearish chatter fr...
Public disclosures can spark headlines, but the real value for everyday investors lies in interpretation. Learn how t...
Chewy, crowned america’s best brand america’s in a 2026 reputation poll, faces a sharp stock drop as brand strength f...
Hot IPOs spark excitement, but do they indicate a market top? This guide compares today’s IPO activity to past bubble...
Honeywell split its aerospace unit into a new company, and the initial market reaction gave investors plenty to study...
NVIDIA delivered blockbuster AI-focused results that strengthen a nvidia buy thesis, while Palantir faces valuation h...
Asana has fallen from pandemic highs, but buying the dip isn’t a guaranteed win. This guide explains the risks, what ...
AppLovin is set to report Q1 2026 after the close, with traders eyeing revenue momentum, margins and AI advertising s...